J HEMATOL ONCOL 润色咨询

Journal of Hematology & Oncology

出版年份:2008 年文章数:702 投稿命中率: 开通期刊会员,数据随心看

出版周期:Irregular 自引率:16.7% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2187866, encodeId=affb218e86669, content=投稿命中率:5.0<br>经验分享:,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed1e5279534, createdName=1483da0bm95(暂无昵称), createdTime=Sun Feb 18 01:16:58 CST 2024, time=2024-02-18, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=567443, encodeId=2f9e56e443c2, content=为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8831636999, createdName=jiawenx, createdTime=Fri Mar 01 00:00:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882300, encodeId=b6d4882300bf, content=投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=Dr H, createdTime=Thu Sep 03 00:33:03 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172085, encodeId=6b8321e2085ce, content=请问接收肺癌靶向治疗方向的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=周大-Jagger, createdTime=Thu Nov 30 12:41:53 CST 2023, time=2023-11-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向:肿瘤<br>经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省)]
    2024-02-18 1483da0bm95(暂无昵称) 来自河北省

    投稿命中率:5.0
    经验分享:,

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2187866, encodeId=affb218e86669, content=投稿命中率:5.0<br>经验分享:,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed1e5279534, createdName=1483da0bm95(暂无昵称), createdTime=Sun Feb 18 01:16:58 CST 2024, time=2024-02-18, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=567443, encodeId=2f9e56e443c2, content=为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8831636999, createdName=jiawenx, createdTime=Fri Mar 01 00:00:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882300, encodeId=b6d4882300bf, content=投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=Dr H, createdTime=Thu Sep 03 00:33:03 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172085, encodeId=6b8321e2085ce, content=请问接收肺癌靶向治疗方向的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=周大-Jagger, createdTime=Thu Nov 30 12:41:53 CST 2023, time=2023-11-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向:肿瘤<br>经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省)]
    2019-03-01 jiawenx

    为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2187866, encodeId=affb218e86669, content=投稿命中率:5.0<br>经验分享:,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed1e5279534, createdName=1483da0bm95(暂无昵称), createdTime=Sun Feb 18 01:16:58 CST 2024, time=2024-02-18, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=567443, encodeId=2f9e56e443c2, content=为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8831636999, createdName=jiawenx, createdTime=Fri Mar 01 00:00:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882300, encodeId=b6d4882300bf, content=投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=Dr H, createdTime=Thu Sep 03 00:33:03 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172085, encodeId=6b8321e2085ce, content=请问接收肺癌靶向治疗方向的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=周大-Jagger, createdTime=Thu Nov 30 12:41:53 CST 2023, time=2023-11-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向:肿瘤<br>经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省)]
    2020-09-03 Dr H

    投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2187866, encodeId=affb218e86669, content=投稿命中率:5.0<br>经验分享:,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed1e5279534, createdName=1483da0bm95(暂无昵称), createdTime=Sun Feb 18 01:16:58 CST 2024, time=2024-02-18, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=567443, encodeId=2f9e56e443c2, content=为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8831636999, createdName=jiawenx, createdTime=Fri Mar 01 00:00:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882300, encodeId=b6d4882300bf, content=投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=Dr H, createdTime=Thu Sep 03 00:33:03 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172085, encodeId=6b8321e2085ce, content=请问接收肺癌靶向治疗方向的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=周大-Jagger, createdTime=Thu Nov 30 12:41:53 CST 2023, time=2023-11-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向:肿瘤<br>经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省)]
    2023-11-30 周大-Jagger 来自天津

    请问接收肺癌靶向治疗方向的文章吗

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2187866, encodeId=affb218e86669, content=投稿命中率:5.0<br>经验分享:,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed1e5279534, createdName=1483da0bm95(暂无昵称), createdTime=Sun Feb 18 01:16:58 CST 2024, time=2024-02-18, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=567443, encodeId=2f9e56e443c2, content=为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8831636999, createdName=jiawenx, createdTime=Fri Mar 01 00:00:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882300, encodeId=b6d4882300bf, content=投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=Dr H, createdTime=Thu Sep 03 00:33:03 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172085, encodeId=6b8321e2085ce, content=请问接收肺癌靶向治疗方向的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=周大-Jagger, createdTime=Thu Nov 30 12:41:53 CST 2023, time=2023-11-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向:肿瘤<br>经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省)]
    2022-02-08 灵动梦幻

    这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新

    9

    展开9条回复
  6. [GetPortalCommentsPageByObjectIdResponse(id=2187866, encodeId=affb218e86669, content=投稿命中率:5.0<br>经验分享:,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed1e5279534, createdName=1483da0bm95(暂无昵称), createdTime=Sun Feb 18 01:16:58 CST 2024, time=2024-02-18, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=567443, encodeId=2f9e56e443c2, content=为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8831636999, createdName=jiawenx, createdTime=Fri Mar 01 00:00:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882300, encodeId=b6d4882300bf, content=投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=Dr H, createdTime=Thu Sep 03 00:33:03 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172085, encodeId=6b8321e2085ce, content=请问接收肺癌靶向治疗方向的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=周大-Jagger, createdTime=Thu Nov 30 12:41:53 CST 2023, time=2023-11-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向:肿瘤<br>经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省)]
    2023-08-07 14889669m60暂无昵称 来自四川省

    请问收个案吗?

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2187866, encodeId=affb218e86669, content=投稿命中率:5.0<br>经验分享:,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed1e5279534, createdName=1483da0bm95(暂无昵称), createdTime=Sun Feb 18 01:16:58 CST 2024, time=2024-02-18, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=567443, encodeId=2f9e56e443c2, content=为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8831636999, createdName=jiawenx, createdTime=Fri Mar 01 00:00:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882300, encodeId=b6d4882300bf, content=投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=Dr H, createdTime=Thu Sep 03 00:33:03 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172085, encodeId=6b8321e2085ce, content=请问接收肺癌靶向治疗方向的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=周大-Jagger, createdTime=Thu Nov 30 12:41:53 CST 2023, time=2023-11-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向:肿瘤<br>经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省)]
    2023-08-18 Forever066 来自广东省

    偏重的研究方向:肿瘤
    经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!

    0

  8. [GetPortalCommentsPageByObjectIdResponse(id=2187866, encodeId=affb218e86669, content=投稿命中率:5.0<br>经验分享:,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed1e5279534, createdName=1483da0bm95(暂无昵称), createdTime=Sun Feb 18 01:16:58 CST 2024, time=2024-02-18, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=567443, encodeId=2f9e56e443c2, content=为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8831636999, createdName=jiawenx, createdTime=Fri Mar 01 00:00:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882300, encodeId=b6d4882300bf, content=投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=Dr H, createdTime=Thu Sep 03 00:33:03 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172085, encodeId=6b8321e2085ce, content=请问接收肺癌靶向治疗方向的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=周大-Jagger, createdTime=Thu Nov 30 12:41:53 CST 2023, time=2023-11-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向:肿瘤<br>经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省)]
    2022-11-09 a201061519

    偏重的研究方向:肿瘤
    经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~

    7

    展开7条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2187866, encodeId=affb218e86669, content=投稿命中率:5.0<br>经验分享:,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed1e5279534, createdName=1483da0bm95(暂无昵称), createdTime=Sun Feb 18 01:16:58 CST 2024, time=2024-02-18, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=567443, encodeId=2f9e56e443c2, content=为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8831636999, createdName=jiawenx, createdTime=Fri Mar 01 00:00:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882300, encodeId=b6d4882300bf, content=投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=Dr H, createdTime=Thu Sep 03 00:33:03 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172085, encodeId=6b8321e2085ce, content=请问接收肺癌靶向治疗方向的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=周大-Jagger, createdTime=Thu Nov 30 12:41:53 CST 2023, time=2023-11-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向:肿瘤<br>经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省)]
    2021-11-05 billljc

    审稿速度:1.0 | 投稿命中率:25.0
    偏重的研究方向:肿瘤
    经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept)

    1

    展开1条回复
  10. [GetPortalCommentsPageByObjectIdResponse(id=2187866, encodeId=affb218e86669, content=投稿命中率:5.0<br>经验分享:,, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=9, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=ed1e5279534, createdName=1483da0bm95(暂无昵称), createdTime=Sun Feb 18 01:16:58 CST 2024, time=2024-02-18, status=1, ipAttribution=河北省), GetPortalCommentsPageByObjectIdResponse(id=567443, encodeId=2f9e56e443c2, content=为什么我在官网上找不到manuscript的具体字体格式?大佬能否提醒一下哪儿有?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=88, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d8831636999, createdName=jiawenx, createdTime=Fri Mar 01 00:00:00 CST 2019, time=2019-03-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=882300, encodeId=b6d4882300bf, content=投稿三天,编辑拒稿,效率还是很高的😂,推荐转投到 biomarker research。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=256, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210104/1a4d3d11af7842afadd172a4a59b32f9/66b07e825e8e4455b5099c678c51e0c6.jpg, createdBy=ab332214260, createdName=Dr H, createdTime=Thu Sep 03 00:33:03 CST 2020, time=2020-09-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2172085, encodeId=6b8321e2085ce, content=请问接收肺癌靶向治疗方向的文章吗, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTLho6ibOpwojItGTZU8OmLlGsyOSL7t2HVFaAIEZlIJqldoZQtUicuCs0xPlfVc8Tmj4ArWfgJJMs6w/132, createdBy=b6432539408, createdName=周大-Jagger, createdTime=Thu Nov 30 12:41:53 CST 2023, time=2023-11-30, status=1, ipAttribution=天津), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了,有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗? , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=50, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向:肿瘤<br>经验分享:这个杂志太bug了,我们投稿两个半月,中间显示有5个reviewer accepted,最后居然说没有找到reviewer,就把我们拒了。简直太不负责任了!, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向:肿瘤<br>经验分享:投过的大神们,Editor appointed 需要多久呢?感谢~~~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0<br>偏重的研究方向:肿瘤<br>经验分享:实验楼不同方向课题组在一年内试投过5篇,2篇10天内拒稿,2篇送外审一个月后拒稿,1篇大修后接收。请3-4个审稿人,审稿人看的非常细,专业性很强,有创新性要求,article不容易中,基本要所有审稿人都给积极意见才能有机会修回。一般一审10天,送外审的再加3周,从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,revise,revise submission,editor assigned,reviewer assigned,under review,reviews completed,editor assigned,accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=135, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=91, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省)]
    2023-05-06 145e9bd3m31暂无昵称 来自广东省

    杂志对数据量和创新性要求还是比较高的,最近有幸中了一篇,编辑的效率还是非常高的,审稿人提的意见也很中肯很有帮助,整体上还是一次不错的投稿体验

    4

    展开4条回复
共308条页码: 1/31页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分